CharlestonPharma Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

CharlestonPharma General Information

Description

Developer of anti-nucleoli antibodies designed to offer related diagnostic tests for cancer patients. The company specializes in creating fully human monoclonal antibodies that specifically target nucleoli located in the plasma membrane and cytoplasm of tumor cells, enabling healthcare providers with antibodies to treat cancer patients as well as the use of cell surface nucleoli in the prognosis and diagnosis of cancer.

Contact Information

Website
www.charlestonpharma.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 645 Meeting Street
  • Suite 4
  • Charleston, SC 29403
  • United States
+1 (843)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 645 Meeting Street
  • Suite 4
  • Charleston, SC 29403
  • United States
+1 (843)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CharlestonPharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Out of Business 18-Mar-2026 Completed Out of Business
10. Secondary Transaction - Private Completed Pre-Clinical Trials
9. Seed Round 26-Feb-2018 Completed Pre-Clinical Trials
8. Seed Round 31-Jan-2017 Completed Pre-Clinical Trials
7. Seed Round 03-Jun-2015 Completed Pre-Clinical Trials
6. Later Stage VC 01-Jan-2015 Completed Pre-Clinical Trials
5. Early Stage VC 01-Jan-2013 Completed Pre-Clinical Trials
4. Early Stage VC 07-Dec-2012 Completed Pre-Clinical Trials
3. Debt - General 07-Dec-2012 $200K $400K Completed Pre-Clinical Trials
2. Seed Round 04-Oct-2011 $200K $200K Completed Pre-Clinical Trials
To view CharlestonPharma’s complete valuation and funding history, request access »

CharlestonPharma Patents

  • 4

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

CharlestonPharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2017181049-A1 Anti-nucleolin agents Inactive 15-Apr-2016
EP-3426691-A1 Anti-nucleolin antibodies Inactive 07-Mar-2016
EP-3426691-A4 Anti-nucleolin antibodies Inactive 07-Mar-2016
WO-2017156032-A1 Anti-nucleolin antibodies Inactive 07-Mar-2016 A61K39/395

Ready to get started?

Request a free trial

CharlestonPharma FAQs

  • When was CharlestonPharma founded?

    CharlestonPharma was founded in 2010.

  • Where is CharlestonPharma headquartered?

    CharlestonPharma is headquartered in Charleston, SC.

  • What industry is CharlestonPharma in?

    CharlestonPharma’s primary industry is Biotechnology.

  • Is CharlestonPharma a private or public company?

    CharlestonPharma is a Private company.

  • What is CharlestonPharma’s current revenue?

    The current revenue for CharlestonPharma is .

  • How much funding has CharlestonPharma raised over time?

    CharlestonPharma has raised $3.55M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process